Regenosca
Lausanne
About Regenosca
Regenosca develops biomaterials serving as an alternative to autologous tissue substitutes for soft tissue repair. Regenosca brings regeneration over scarring with our medical devices.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $1.4M
- Funding stage: Seed
- Last round: Pre-Seed (Jul 2024)
- Website: regenosca.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/regenosca-137178 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.